期刊文献+

血液透析患者丙型肝炎病毒感染的危险因素及交互作用 被引量:9

Risk factors of hepatitis C virus infection and the interactions in maintained hemodialysis patients
原文传递
导出
摘要 目的 了解维持性血液透析(MHD)患者HCV感染的危险因素及其交互作用.方法 采用多中心整群抽样方法,面对面询问,收集435例MHD患者的人口学,以及与HCV感染发生可能相关的行为因素等资料,同时检测抗-HCV和HCV RNA水平.采用非条件Logistic回归方法计算OR值和95%CI,并进行单因素和调整可能混杂因素的多因素回归分析.结果 MHD患者抗-HCV阳性30例,其中5例HCV RNA阳性,HCV感染率为6.9%.持续透析时间和HCV感染呈正相关趋势(x^2 =30.89,P<0.01).多因素Logistic回归分析结果显示,HBV感染、长期使用免疫抑制剂和持续透析时间≥3年是HCV感染的独立危险因素(OR值分别为2.71、4.03和5.84,P值分别为0.026、0.006和0.001).HBV感染与透析时间≥3年,既存在相加交互作用,其超额相对危险度(RERI)、交互作用归因比(AP)和交互作用指数(S)分别为10.72、0.60和2.74,同时又存在相乘交互作用(OR=6.26,95%CI:2.25~17.44).结论 长期使用免疫抑制剂和持续透析时间≥3年可能是HCV感染的危险因素,同时,HBV感染和透析时间≥3年间存在相加和相乘交互作用. Objective To investigate the risk factors of hepatitis C virus (HCV) infection and their interactions among maintained hemodialysis (MHD) patients.Methods A multicenter cluster-sampled cross sectional study was conducted in Taiyuan city,Shanxi Province.Epidemiological data including demographical information and other related risk behavior of HCV infection were collected by face-to-face interviews using a self-designed questionnaire in 435 MHD patients.Meanwhile,venous blood samples of hemodialysis patients were collected for testing serum anti-HCV and HCV RNA levels.Unconditional Logistic regression was used to estimate adjusted odds ratio (OR) and 95 % confidence intervals (CI) in univariate and multivariate analyses to adjust the potential confounding factors.Results Thirty cases had positive anti-HCV,5 of which had positive serum HCV RNA.The prevalence of HCV infection in MHD patients was 6.9%.There was positive correlation between the duration of dialysis and HCV infection (x^2 =30.89,P〈 0.01).The multivariate Logistic regression analysis showed that hepatitis B virus (HBV) infection,long-term use of immunosuppressive agents and the duration of dialysis ≥3 years were the independent risk factors for HCV infection (OR values were 2.71,4.03 and 5.84,respectively; P values were 0.026,0.006 and 0.001,correspondingly).Data from interaction analysis showed that there were both additive interaction (the relative excess risk due to interaction (RERI),10.72; the attributable proportion (AP) due to interaction,0.60; the synergy indexs,2.74) and multiplicative interaction (OR=6.26; 95%CI,2.25-17.44) between HBV infection and the duration of dialysis ≥3 years.Conclusions Long-term use of immunosuppressive agents and the duration of dialysis ≥3 years are probably the risk factors of HCV infection.Besides,nfection of HBV and the duration of dialysis ≥3 years have both additive and multiplicative interactions on the infection of HCV.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2014年第5期293-298,共6页 Chinese Journal of Infectious Diseases
基金 国家“十二五”艾滋病和病毒性肝炎等重大传染病防治专项--子课题3乙肝疫苗免疫策略研究资助项目(2012ZXI0002001-003)
关键词 肾透析 丙型肝炎病毒属 危险因素 交互作用 Renal dialysis Hepacivirus Risk factor Interaction
  • 相关文献

参考文献27

  • 1World Health Organization (WHO). Hepatitis C. Geneva: WHO, 2013[EB/OL]. [2013-11-22]. http://www, who. int/ mediaeentre/factsheets/fs164/cn/.
  • 2Tielemans CL, Vlasak J, Kosa D, et al. Immunogenicity and safety of an investigational AS02 (v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative trials [J]. Vaccine, 2011,29(6) :1159 1166.
  • 3Surquin M, Tielemans C, Nortier J, et al. Anti-HBs antibody persistence following primary vaccination with an investigational AS02 (v)-adjuvanted hepatitis I3 vaccine in patients with renal insufficiency [J]. Hum Vaccin, 2011,7 (9) : 913-918.
  • 4Ramezani A, Eslamifar A, Banifazl M, et al. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients[J]. Int J Clin Pract, 2009,63(3) :394- 397.
  • 5Dunford L, Carr MJ, Dean J, et al. Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi- transfused patients involving diverse and novel virus variants [J]. PLoS One, 2012,7(8):e41266.
  • 6Sarkari B, Eilami O, Khosravani A, et al. High prevalence of hepatitis C infection among high risk groups in Kohgiloyeh and Boyerahraad Province, Southwest Iran [J]. Arch Iran Med, 2012,15(5) :271-274.
  • 7Fabrizi F, Takkouche B, Lunghi G, et al. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies [J]. J Viral Hepat, 2007,14(10): 697-703.
  • 8Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction [J]. Eur J Epidemiol, 2005, 20(7) : 575-579.
  • 9邱宏,余德新,王晓蓉,付振明,谢立亚.logistic回归模型中交互作用的分析及评价[J].中华流行病学杂志,2008,29(9):934-937. 被引量:93
  • 10Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center [J]. Saudi J Kidney Dis Transpl, 2008,19(1) :110-115.

二级参考文献28

  • 1McCruden EA,Welch S,Batchelor B,et al.Hepatitis C virus infection detected by antibody tests and the polymetase chain reaction as a cause of liver dysfunction in renal transplant recipients[J].JMed Virol,1994,42(2):158-63.
  • 2Brunson ME,LauJY,Davis GL,et al.Non-A,Non-B hepatitis and elevated serum aminotransferases in renal transplant patients [J].Transplantation,1993,56(7):1364-7.
  • 3Roth D.Hepatitis C virus:the nephrologist's view[J].AmJKidney Dis,1995,25(1):3-16.
  • 4Mathuin P,Mouquet C,Poynard T,et al.Impact of hepatitis B and C virus on kidney transplantation outcome[J].Hepatology,1999,29(1):257-63.
  • 5Roth D,Zucker K,Cirocco R,et al.The impact of hepatitis C virus infection on renal allograft recipients[J].Kidney Iht,1994,45(1):238-44.
  • 6夏穗生.临床移植学[M].杭州:浙江科学技术出版社,1991.137-42.
  • 7Boletis J,Deliadetsima J,Psimenou E,et al.Liver biopsy is essential in anti-HCV (+) renal transplant patients irrespective of liver function tests and serology for HCV[J].Transplant Proc,1995,27(1):945-7.
  • 8Sagnelli E,Piccinino F,Marzollo G,et al.Effect ofimmuno-suppressive therapy on HBsAg positive chronic active hepatitis in relation to presence and absence of HBsAg and anti-Hbe [J].Hepatology,1983,3(5):690-5.
  • 9Jain AK,FungJJ.Hepatitis C virus and renal failure[J].Transplant Proc,2003,35(1):4168.
  • 10Kramer P,ten Kate FW,Bijnen AB,et al.Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients [J].Lancet,1984,1 (8384):989-90.

共引文献164

同被引文献65

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部